Scintigraphy with 123I-Serum amyloid P component in Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 12, Issue 3, 1998, Pages 208-210

  Lovat, Laurence B ^a   O'Brien, Anthony A J ^a   Armstrong, Sally F ^a   Madhoo, Sheril ^a   Bulpitt, Christopher J ^a   Rossor, Martin N ^b   Pepys, Mark B ^a   Hawkins, Philip N ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Alzheimer disease (AD; Amyloid; A protein; Serum amyloid P component (SAP)

Indexed keywords

AMYLOID BETA PROTEIN; IODINE 123; SERUM AMYLOID P; DIAGNOSTIC AGENT; RADIOIODINATED HUMAN SERUM ALBUMIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; BRAIN; METABOLISM; MIDDLE AGED; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN, RADIO-IODINATED; SERUM AMYLOID P-COMPONENT;

EID: 0032217204     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199809000-00014     Document Type: Article

References (18)

1. Coria F, Castano E, Prello F, et al. Isolation and characterization of amyloid P component form Alzheimer's disease and other types of cerebral amyloidosis. Lab Invest 1988;58:454-8.
2. Duong T, Pommier EC, Scheibel AB. Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol 1989;78:429-37.
3. Duong T, Doucette T, Zidenberg NA, Jacobs RW, Scheibel AB. Microtubule-associated proteins tau and amyloid P component in Alzheimer's disease. Brain Res 1993;603:74-86.
4. Hawkins PN. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo. Clin Sci 1994;87:289-95.
5. Hawkins PN, Myers MJ, Lavender JP, Pepys MB. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component. Lancet 1988;i:1413-8.
6. 123I-labeled serum amyloid P component. N Engl J Med 1990;323:508-13.
7. Hawkins PN, Tyrell P, Jones T, et al. Metabolic and scintigraphic studies with radiolabeled serum amyloid P component in amyloidosis: applications to cerebral deposits and Alzheimer disease with positron emission tomography. Bull Clin Neurosci 1991;56:178-90.
8. Hawkins PN, Rossor MN, Gallimore JR, Miller B, Moore EG, Pepys MB. Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer disease. Biochem Biophys Res Commun 1994;201:722-6.
9. Iseki E, Amano N, Matsuishi T, Yokoi S, Arai N, Yagishita S. A case of familial, atypical Alzheimer's disease: immunohistochemical study of amyloid P component. Neuropathol Appl Neurobiol 1988;14:169-74.
10. Joachim CL, Mori H, Selkoe DJ. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature 1989;341: 226-30.
11. Kalaria RN, Golde TE, Cohen ML, Younkin SG. Serum amyloid P component in Alzheimer's disease. Implications for dysfunction of the blood-brain barrier. Ann NY Acad Sci 1991a;640:145-8.
12. Kalaria RN, Golde TE, Cohen M, Younkin LH, Younkin S. Absence of detectable mRNA of serum amyloid P component (SAP) in human brain, choroid plexus, and meninges suggests that the presence of SAP in CSF is due to transport across the blood-brain barrier. J Neuropathol Exp Neurol 1991b;50:339.
13. Kalaria RN, Perry G. Amyloid P component and other acute-phase proteins associated with cerebral Aβ-deposits in Alzheimer's disease. Brain Res 1993;631:151-5.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
15. Pepys MB. Amyloidosis. In: Frank MM, Austen KF, Claman HN, Unanue ER, eds. Samter's immunologic diseases, 5th ed. Boston: Little, Brown, 1994:637-55.
16. Skodras G, Peng JH, Parker JC, Kragel PJ. Immunohistochemical localization of amyloid beta-protein deposits in extracerebral tissues of patients with Alzheimer's disease. Ann Clin Lab Sci 1993;23:275-80.
17. Tennent GA, Lovat LB, Pepys MB. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer's disease and systemic amyloidosis. Proc Natl Acad Sci USA 1995;92:4299-303.
18. Wen GY, Wisniewski HM, Blondal H, et al. Presence of non-fibrillar amyloid beta protein in skin biopsies of Alzheimer's disease (AD), Down's syndrome and non-AD normal persons. Acta Neuropathol Berl 1994;88:201-6.